SGRY · Surgery Partners, Inc.
$16.41
+0.83 (+5.33%)
At close · Jul 29
Market Cap
$2.04B
Shares
130.79M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$200,000,000
as of 2026-02-26
Remaining Authorization
$46,000,000
as of 2025-12-31
Program Utilization
77.0%
$154,000,000 used of $200,000,000
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-02-26 | $200,000,000 | — | — | — | 10-Q , filed 2026-05-05 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2020-12-31 | $0 | 10-K, filed 2021-03-10 |
| 2019-12-31 | $0 | 10-K, filed 2021-03-10 |
| 2018-12-31 | $2,000,000 | 10-K, filed 2021-03-10 |
| 2016-12-31 | $0 | 10-K, filed 2017-03-10 |
| 2015-12-31 | $0 | 10-K, filed 2017-03-10 |
| 2014-12-31 | $3,143,000 | 10-K, filed 2017-03-10 |
| 2013-12-31 | $0 | 10-K, filed 2016-03-11 |
Key facts
CIK
1638833
CUSIP
86881A100
13F (30d)
28 filings
28 filers
Visit website
Investor relations